Cytokine responses and progression to active tuberculosis in HIV-1-infected Ugandans: a prospective study

被引:24
作者
Elliott, AM
Hodsdon, WS
Kyosiimire, J
Quigley, MA
Nakiyingi, JS
Namujju, PB
Watera, C
French, N
Gilks, CF
Dockrell, HM
Whitworth, JAG
机构
[1] Uganda Virus Res Inst, Entebbe, Uganda
[2] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England
[3] Univ Liverpool Liverpool Sch Trop Med, London L3 5QA, England
[4] Univ London Imperial Coll Sci & Technol, London W2 1PG, England
基金
英国惠康基金;
关键词
tuberculosis; HIV; cytokines; Uganda;
D O I
10.1016/j.trstmh.2004.01.007
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Identifying correlates of immunity or susceptibility to disease promotes understanding of pathogenesis and development of diagnostic tools, treatments, and vaccines. There is evidence that type 1 cytokine responses are associated with protection against tuberculosis, and suppression of type 1, or switching to type 2 responses, with susceptibility, but this has not been studied prospectively. We studied a cohort of 631 HIV-1-infected Ugandan adults. At enrolment we performed whole blood cultures for type 1 (interferon [IFN]-gamma, interleukin [IL]-2) and type 2/immunosuppressive (IL-5, IL-10) responses to mycobacterial antigens (purified protein derivative [PPD] and culture filtrate proteins [CFP]). The incidence of tuberculosis was not associated with IFN-gamma responses, but was higher among participants with IL-2 responses (adjusted rate ratios [RR]: PPD 3.48; CFP 3.99; P < 0.001). For tuberculin skin test-positive participants, high incidence was also associated with an IL-10 response to PPD (adjusted RR 6.24, P = 0.03); for those with a BCG scar, high incidence was associated with positive IL-5 responses (adjusted RRs: PPD 3.64, P = 0.006; CFP 3.44, P = 0.04). The association with IL-2 production may reflect a response to tuberculous infection or to activating disease; the associations with IL-10 and IL-5 are in keeping with the expected rote of immunosuppressive or type 2 cytokines. (C) 2004 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:660 / 670
页数:11
相关论文
共 32 条
[1]   Specific immune-based diagnosis of tuberculosis [J].
Andersen, P ;
Munk, ME ;
Pollock, JM ;
Doherty, TM .
LANCET, 2000, 356 (9235) :1099-1104
[2]   Can eradication of helminthic infections change the face of AIDS and tuberculosis? [J].
Bentwich, Z ;
Kalinkovich, A ;
Weisman, Z ;
Borkow, G ;
Beyers, N ;
Beyers, AD .
IMMUNOLOGY TODAY, 1999, 20 (11) :485-487
[3]   DISSEMINATED TUBERCULOSIS IN INTERFERON-GAMMA GENE-DISRUPTED MICE [J].
COOPER, AM ;
DALTON, DK ;
STEWART, TA ;
GRIFFIN, JP ;
RUSSELL, DG ;
ORME, IM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2243-2247
[4]   HIV-1/AIDS and the control of other infectious diseases in Africa [J].
Corbett, EL ;
Steketee, RW ;
ter Kuile, FO ;
Latif, AS ;
Kamali, A ;
Hayes, RJ .
LANCET, 2002, 359 (9324) :2177-2187
[5]  
DELPRETE G, 1993, J IMMUNOL, V150, P353
[6]   Global burden of tuberculosis - Estimated incidence, prevalence, and mortality by country [J].
Dye, C ;
Scheele, S ;
Dolin, P ;
Pathania, V ;
Raviglione, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07) :677-686
[7]   Eosinophilia and progression to active tuberculosis in HIV-1-infected Ugandans [J].
Elliott, AM ;
Kyosiimire, J ;
Quigley, MA ;
Nakiyingi, J ;
Watera, C ;
Brown, M ;
Joseph, S ;
French, N ;
Gilks, CF ;
Whitworth, JAG .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2003, 97 (04) :477-480
[8]  
Elliott AM, 1999, INT J TUBERC LUNG D, V3, P239
[9]   AN ESSENTIAL ROLE FOR INTERFERON-GAMMA IN RESISTANCE TO MYCOBACTERIUM-TUBERCULOSIS INFECTION [J].
FLYNN, JL ;
CHAN, J ;
TRIEBOLD, KJ ;
DALTON, DK ;
STEWART, TA ;
BLOOM, BR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2249-2254
[10]   23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial [J].
French, N ;
Nakiyingi, J ;
Carpenter, LM ;
Lugada, E ;
Watera, C ;
Moi, K ;
Moore, M ;
Antvelink, D ;
Mulder, D ;
Janoff, EN ;
Whitworth, J ;
Gilks, CF .
LANCET, 2000, 355 (9221) :2106-2111